- Randomized noninferiority trial of 114 patients scheduled for anterior cruciate ligament repair at one Toronto hospital, using a fabricated low-risk research trial with active deception.
- Patients were invited to the fabricated trial either at a virtual preanesthesia visit in advance or on the day of surgery.
- Participation in the fabricated trial was 45% (26/58) for same-day consent versus 30% (17/56) for advance consent, and perceived coercion did not differ between groups.
- The authors conclude that same-day consent restrictions based on undue influence concerns may be a structural barrier to low-risk trial participation without empirical support.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Single-center, patient- and assessor-blinded randomized trial of 192 women undergoing elective gynecological laparoscopic surgery, with 364 assessed.
- Participants wore passive noise-attenuating earmuffs from induction to end of surgery or received usual care, and all received dexamethasone and palonosetron.
- PONV within 48 hours occurred in 35.4% with noise isolation versus 52.1% with control (adjusted risk difference -0.179, 95% CI -0.318 to -0.040; P = 0.012).
- Authors conclude noise isolation was associated with lower PONV incidence and severity; secondary endpoints favored it after FDR correction, but adverse events and recovery quality did not differ.
- Multicentre randomised trial of 400 children aged 2 to under 7 years undergoing adenotonsillectomy at four tertiary hospitals in China.
- Children were randomised 1:1 to ventilation with a laryngeal mask airway or an endotracheal tube.
- Any perioperative respiratory adverse event occurred in 22.5% of the LMA group versus 57.5% of the ETT group (absolute risk difference -35.0 points, 95% CI -43.5 to -25.7; P<0.001).
- The authors conclude that LMA ventilation by experienced anaesthesiologists produced fewer respiratory adverse events, and neither group had serious adverse events.
- Randomized, double-blind dose-finding trial of 99 children aged 1-6 years undergoing adenotonsillectomy, with a glucose control group.
- Children received oral 10% glucose or oral esketamine at 1, 2, or 3 mg/kg, given 30 minutes before anesthesia.
- At cannulation, all esketamine doses improved sedation and analgesia (overall p < 0.001), greatest at 3 mg/kg, where median FLACC was 0.00 versus 6.00 in controls.
- The authors favored 2 mg/kg for balancing efficacy and safety, and 3 mg/kg for superior analgesia and opioid sparing (remifentanil 120 vs 240 μg, p = 0.001).
- Multicentre, randomised, double-blind trial in 873 analysed adults (914 randomised) undergoing video-assisted thoracoscopic lung resection.
- Perioperative low-dose esketamine (bolus at induction, then intra- and postoperative infusion for 48 h) was compared with normal saline.
- Chronic pain at 3 months was 14.7% with esketamine versus 21.2% with control (adjusted OR 0.62, 95% CI 0.43-0.90; P=0.013).
- A post hoc definition using NRS ≥3 during coughing also favoured esketamine (adjusted OR 0.39, 95% CI 0.19-0.84; P=0.015), and the authors report no increase in adverse effects.
- Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
- Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
- At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
- Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
- Protocol for a multicentre randomized controlled trial in patients aged 60 or older with anaemia (haemoglobin ≤90 g/l) undergoing surgery for hip fracture.
- Compares a liberal transfusion strategy (haemoglobin target 90 to 110 g/l) with a restrictive strategy (target 75 to 90 g/l) from randomization to discharge or 30 days.
- No efficacy results are reported; the primary outcome is a composite of death or major adverse cardiac events, adjudicated by blinded experts, with quality of life assessed at 120 days.
- The authors reduced the target sample size from 1,984 to 842 and added myocardial injury after non-cardiac surgery (MINS) to the primary outcome after recruitment fell short.
- Single-center, prospective cluster-randomized trial by month in cardiac surgery patients receiving intraoperative cryoprecipitate, stopped early at 170 of 502 planned patients.
- Pathogen-reduced cryoprecipitated fibrinogen complex (PR CRYO, storable at room temperature post-thaw) was compared with conventional cryoprecipitate (Cryo).
- Total blood components transfused were identical (6 units, IQR 3-12, p > 0.9), while PR CRYO was issued 19 min faster (12 vs. 31 min, p < 0.001) and transfusion began 16 min sooner (46 vs. 62 min, p = 0.008).
- No reduction in 30-day transfusions was shown, adverse events and 3-day transfusions were similar, and equivalence could not be formally concluded.
- Single-center randomized trial of 100 adults aged 65 or older with RAI-C scores above 15, undergoing elective gastrointestinal surgery in Shanghai.
- Participants were randomized 1:1 to fluid-responsiveness-guided preinduction volume optimization using passive leg raising and echocardiography, or usual care.
- Any MAP below 65 mmHg during postinduction minutes 1 to 15 occurred in 38% versus 72% (risk difference -34.0 points, 95% CI -50.1 to -14.5; relative risk 0.53, 95% CI 0.36 to 0.78; P = .001).
- The authors concluded that optimization reduced early postinduction hypotension, but noted that differences in hypotension depth and burden were modest.
- This prospective randomized trial enrolled 271 adults undergoing elective sternotomy at a single center, randomized 1:1:1 to standard therapy, ESP block, or SPIP block.
- Both fascial plane blocks were added to a multimodal analgesic regimen and compared with the control group receiving standard therapy alone.
- Opioid use did not differ significantly on postoperative days 0 to 2; a day 3 difference favored ESP (p = 0.047). Maximum pain scores were lower in both block groups on days 0 to 3 (POD 1 p < 0.001, POD 2 p < 0.001, POD 3 p = 0.002).
- The authors conclude that patients undergoing sternotomy may benefit from adding either ESP or SPIP blocks to a multimodal postoperative regimen.
- Multicenter randomized non-inferiority trial of 210 children under 2 years undergoing single-stage midshaft or distal hypospadias repair, with 161 completing 3-month follow-up.
- Children were randomized to caudal block (n=79 analyzed) or penile block (n=82 analyzed), both under general anesthesia.
- Urethrocutaneous fistula occurred in 8.9% of caudal and 7.3% of penile block patients (RR 0.98; 95% CI 0.35 to 2.76; p=0.9).
- Caudal block was associated with less intraoperative and rescue opioid use and lower PACU FLACC scores, though the authors call these findings exploratory given early termination and wide CIs.
- Randomized controlled trial of 60 children undergoing adenotonsillar surgery, allocated to methylprednisolone, dexamethasone, or no corticosteroid.
- Children received methylprednisolone 1 mg/kg, dexamethasone 0.2 mg/kg, or no steroid before sugammadex reversal of rocuronium block.
- Reversal time was longer with methylprednisolone (82.8 ± 16.1 s) than with dexamethasone (63.4 ± 13.4 s) or control (56.1 ± 13.7 s), p < 0.001.
- Extubation time followed a similar pattern, while postoperative pain, nausea, and adverse event rates did not differ significantly between groups.
- This delirium-focused secondary analysis of a single-centre, double-blind, placebo-controlled trial enrolled adults having head and neck cancer surgery with free-flap reconstruction.
- Patients received intraoperative dexmedetomidine at 0.3 μg/kg/h until 1 hour before surgery ended, or comparable volumes of saline placebo.
- Delirium over the first 5 postoperative days occurred in 14.9% (7/47) of dexmedetomidine patients versus 34.7% (17/49) of placebo patients (adjusted OR 0.31, 95% CI 0.10-0.92; p = 0.036).
- Pain and early sleep were reported as improved with dexmedetomidine, and haemodynamic adverse events and postoperative complications did not differ significantly between groups.
- Multicenter, double-blind, placebo-controlled randomized trial in 1210 patients (1188 analyzed at day 30) undergoing elective curative-intent digestive cancer surgery across 23 French hospitals.
- Patients received 20 mg/kg intravenous methylprednisolone at anesthesia induction or an identical-appearing placebo.
- Major postoperative complications within 30 days did not differ significantly: 23% (139/594) with methylprednisolone vs 20% (119/594) with placebo; P = .16.
- Secondary outcomes, including postoperative infections (P = .75), intra-abdominal infections (P = .27), wound healing problems (P = .13) and length of stay (P = .93), also showed no difference; the authors advise against routine use.
- A registry-based cross-sectional study of 74 adult interventional regional anesthesia trials initiated 2017-2024 that had posted results and linked publications on ClinicalTrials.gov.
- The authors compared the earliest and most recent registry versions of each trial's outcome fields to identify changes in outcome definitions, timing, and classifications.
- 91.9% of trials had at least one substantive outcome change, and 37.8% had high-impact modifications. The latest substantive change came after primary completion in 47.1% and after publication in 51.5%.
- None of these latest modifications were disclosed, and secondary outcomes were added or removed more often than primary outcomes.
- Pragmatic, open-label, multicenter randomized trial of 2508 adults aged 50 or older having elective major noncardiac surgery at 49 UK NHS hospitals.
- Patients were randomized 1:1 to maintenance of general anesthesia with propofol TIVA or volatile inhalational agents, with other perioperative care left to clinician discretion.
- Days alive and at home at 30 days were similar (22.5 vs 22.4 days; incidence rate ratio 1.00, 95% CI 0.99-1.02; adjusted P = .68).
- TIVA was associated with lower reported thirst, hoarseness, and nausea/vomiting; major complications (12.4% overall) did not differ between groups.
- Prospective randomized controlled trial of 254 children aged 3-9 years undergoing elective adenotonsillectomy.
- Children were intubated with a room-temperature polyvinyl chloride endotracheal tube or one softened and pre-warmed to 37°C.
- Overall perioperative respiratory adverse events were 14.1% with warmed tubes versus 24.6% with room-temperature tubes (p = 0.039), with lower laryngospasm and postoperative coughing.
- Room-temperature tube use was an independent predictor (adjusted OR 2.29, 95% CI 1.16-4.54); the authors call for multicenter confirmation.
- A preplanned secondary analysis of a single-center, double-blind, 3-arm randomized trial in 34 adults undergoing elective CABG with cardiopulmonary bypass.
- Patients received albumin-based, gelofusine-based, or retrograde autologous priming (reference), with Stewart acid-base variables measured at five perioperative time points.
- Bypass initiation caused metabolic acidosis (-0.1 pH, -4.3 mmol/L standard base excess, -6.6 mEq/L effective strong ion difference), and these measures did not differ among priming strategies.
- Each extra liter of crystalloid independently lowered pH (-0.011; p = 0.035) and effective strong ion difference (-1.03 mEq/L; p = 0.025), which the authors attribute to crystalloid load rather than colloid choice.
- Post hoc secondary analysis of two trials across 30 hospitals, including 1963 adults having major abdominal or thoracic surgery.
- Compared patients given antiemetic-dose intraoperative corticosteroids with those who did not, using inverse probability of treatment weighting for preoperative confounders.
- After weighting, steroids were not significantly associated with fewer postoperative pulmonary complications (OR 0.86, 95% CI 0.62-1.18, P=0.347), though the unweighted rates were lower (9.3% vs 14.0%).
- PACU PaO2/FiO2 ratio was modestly higher with steroids (adjusted mean difference 19.9 mm Hg, 95% CI 0.64-39.1, corrected P=0.043).
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- International, double-blind, placebo-controlled randomised trial of 955 adults with anaemia awaiting elective cardiac surgery, across 33 hospitals in 10 countries.
- Participants were randomised to 1000 mg intravenous iron or placebo 1 to 26 weeks before surgery.
- Days alive and at home at 90 days were 81.1 with iron versus 80.0 with placebo (adjusted median difference 1.0 day, 95.4% CI 0.0 to 2.1, P=0.041).
- Transfusion during hospital stay was 61.1% with iron versus 68.2% with placebo (RR 0.90, 95% CI 0.82 to 0.99, P=0.027); complications and stay did not differ.